Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 3, 2026

Rapid Mix Preparation of Bioinspired Nanoscale Hydroxyapatite for Biomedical Applications
05:41

Rapid Mix Preparation of Bioinspired Nanoscale Hydroxyapatite for Biomedical Applications

Published on: February 23, 2017

Development of hydroxyapatite-ciprofloxacin bone-implants using "Quality by design".

Amit Kumar Nayak1, Bibek Laha, Kalyan Kumar Sen

  • 1Department of Pharmaceutics, Gupta College of Technological Sciences, Asansol-713301, India. amitkrnayak@yahoo.co.in

Acta Pharmaceutica (Zagreb, Croatia)
|March 17, 2011
PubMed
Summary

This study explores how to create bone implants that slowly release ciprofloxacin, an antibiotic, using a method called Quality by Design. The researchers tested different conditions, such as how much drug to add and how fast to mix the ingredients. They found that the drug could be incorporated into the implant without forming crystals, even at high concentrations. The implants released the drug over several weeks, and the release pattern matched a known model for slow drug release. The study shows that using a structured design approach can help make implants with consistent and predictable drug delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transurethral Ropivacaine (100 mg) Bladder Irrigation Reduces the Incidence of Bladder Discomfort in Transurethral Resection of Bladder Tumor: A Randomized Double-blind Trial.

Annals of African medicine·2026
Same author

Correction to "Surface Tailoring-Modulated Bifunctional Oxygen Electrocatalysis with CoP for Rechargeable Zn-Air Battery and Water Splitting".

ACS applied materials & interfaces·2025
Same author

Formulation and Evaluation of Capecitabine-Loaded Microsponges for Colon Targeting.

Current drug delivery·2025
Same author

Carbohydrate biopolymer-based nanocomposites as strategic modality in addressing brain cancer.

International journal of biological macromolecules·2025
Same author

Dextran-based vehicle for gene transfection: A lesson learned by nature.

International journal of biological macromolecules·2025
Same author

Metformin and its Nanoformulations in Cancer Prevention and Therapy.

Current pharmaceutical design·2025

Area of Science:

  • Biomedical materials engineering
  • Pharmaceutical formulation science
  • Orthopedic implant development

Background:

Current research on bone implants often focuses on mechanical properties and biocompatibility. However, the controlled release of antibiotics within these implants remains an area with unresolved challenges. Prior research has shown that hydroxyapatite is a promising scaffold for drug delivery in orthopedic applications. Yet, the precise control of drug loading and release mechanisms is still under investigation. Existing methods for incorporating antibiotics into implants lack systematic optimization strategies. This gap motivated the need for a more structured approach to formulation development. The Quality by Design framework offers a solution by emphasizing process control and predictive modeling. No prior work had resolved the optimal synthesis parameters for HAp-ciprofloxacin systems. This study addresses that gap by applying design-based optimization techniques.

Purpose Of The Study:

The goal of this research is to develop a reliable method for incorporating ciprofloxacin into hydroxyapatite bone implants. The study aims to identify key synthesis parameters that influence drug loading and release. A factorial design approach was selected to systematically evaluate multiple variables. The researchers propose that this method can improve the consistency of drug delivery in orthopedic implants. The study focuses on optimizing drug concentration within the implant matrix. The Quality by Design framework was used to guide the experimental process. The researchers aim to demonstrate that this approach can predict and achieve desired outcomes. The study also seeks to validate the correlation between synthesis parameters and drug release behavior.

Keywords:
bone implant developmentdrug release modelingpharmaceutical formulationhydroxyapatite composites

Frequently Asked Questions

The study shows that ciprofloxacin can be sustained in implants for several weeks using the Korsmeyer-Peppas model.

Guar gum acts as a binder to improve the structural integrity of the HAp-ciprofloxacin composite.

The model was selected because it fits the sustained release pattern observed in the in vitro experiments.

X-ray powder diffraction showed that ciprofloxacin remained noncrystalline even at high concentrations.

More Related Videos

An Improved Mechanical Testing Method to Assess Bone-implant Anchorage
11:51

An Improved Mechanical Testing Method to Assess Bone-implant Anchorage

Published on: February 10, 2014

Related Experiment Videos

Last Updated: Jun 3, 2026

Rapid Mix Preparation of Bioinspired Nanoscale Hydroxyapatite for Biomedical Applications
05:41

Rapid Mix Preparation of Bioinspired Nanoscale Hydroxyapatite for Biomedical Applications

Published on: February 23, 2017

An Improved Mechanical Testing Method to Assess Bone-implant Anchorage
11:51

An Improved Mechanical Testing Method to Assess Bone-implant Anchorage

Published on: February 10, 2014

Main Methods:

The research team used a 23 factorial design to evaluate three synthesis parameters. These included drug amount, stirring speed, and orthophosphoric acid addition rate. The precipitation technique was selected for synthesizing HAp-ciprofloxacin composites. A first-order polynomial equation was applied to optimize drug concentration. The implants were prepared with 1.5% guar gum as a binding agent. X-ray powder diffraction was used to analyze the crystallinity of the drug. Fourier-transform infrared spectroscopy confirmed the presence of ciprofloxacin in the matrix. Scanning electron microscopy provided structural insights into the implant composition.

Main Results:

The study found that the observed drug concentrations matched the predicted values from the optimization model. At the highest drug concentration of 76.6 ± 0.5%, ciprofloxacin remained noncrystalline. The in vitro release of ciprofloxacin lasted for several weeks from the implants. The release pattern followed the Korsmeyer-Peppas model closely. The factorial design successfully identified optimal synthesis conditions. The use of guar gum as a binder improved the structural integrity of the implants. The XRPD and FTIR results confirmed the successful incorporation of the drug. The study demonstrated that the Quality by Design approach can reliably predict and achieve desired drug release profiles.

Conclusions:

The authors suggest that the Quality by Design approach is effective for optimizing HAp-ciprofloxacin implants. The study supports the use of factorial design to identify key synthesis parameters. The observed drug release behavior aligns with the Korsmeyer-Peppas model. The noncrystalline state of ciprofloxacin at high concentrations was confirmed. The researchers propose that this method can enhance the consistency of drug delivery. The study highlights the importance of binder selection in implant formulation. The results suggest that the optimization model accurately predicts drug concentration. The authors conclude that this approach can be applied to other antibiotic-implant systems.

The highest ciprofloxacin concentration was 76.6 ± 0.5% by mass.

The authors propose that this approach can reliably predict and achieve optimal drug delivery in implants.